CQDM: Canada on the brain

The Quebec Consortium for Drug Discovery and Brain Canada have announced at least C$10 million (US$9.2 million) in funding for a new program to develop tools to accelerate the discovery of neurological disease therapies.

Under the three-year Focus on Brain program, the Quebec Consortium (CQDM) and the not-for-profit Brain Canada will fund collaborative projects at research institutions and small companies across Canada. The goal is to generate tools, technologies and platforms that could enable industry to overcome some of the barriers that impede drug discovery in neurology...